Rebastinib
An orally bioavailable tyrosine kinase inhibitor
| Catalog Number | 21465 |
| Alternative Name(s) | DCC-2036 |
| Research Area | Abl family & Bcr-Abl Signaling|Cancer|Cell Signaling|Growth Factor Receptor Signaling|SRC Family Signaling |
| Molecular Formula | C30H28FN7O3 |
| CAS# | 1020172-07-9 |
| Purity | ≥98% |
| Inchi | InChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40) |
| Inchi Key | WVXNSAVVKYZVOE-UHFFFAOYSA-N |
| SMILES | CC(C)(C1=NN(C2=CC=C3C(C=CC=N3)=C2)C(N([H])C(N(C4=CC=C(C=C4F)OC5=CC(C(N(C)[H])=O)=NC=C5)[H])=O)=C1)C |
| Size | 5 mg |
| Supplier Page | https://www.caymanchem.com/product/21465 |